A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma
Figure 4
Effect of anti-CD25 mAb immunotherapy on TILs of glioma-bearing mice. (a) FACS dot plot of TILs analyzed by CD4 and CD8 double staining. (b) Distribution of CD4+ and CD8+ T cells within context of anti-CD25 glioma immunotherapy, compared between brain and bone marrow. Data are presented as the percentage average of cells and represent the mean of three individual experiments ().